Position in ACLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$118,111,429
+$55,646,113 QoQ
Shares Held
1,028,666
+7.4% QoQ
Ownership
1.76%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. ACLX ranks #32 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ACLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,111,429 | 1,028,666 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $62,465,316 | 958,057 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $76,049,557 | 926,304 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $63,333,081 | 961,778 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $66,947,423 | 1,020,540 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $75,081,503 | 979,026 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $81,419,493 | 974,967 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $51,612,915 | 935,186 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $58,315,518 | 838,469 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $43,589,811 | 785,402 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $26,517,257 | 739,054 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $21,666,909 | 685,228 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,303,019 | 561,604 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $16,876,974 | 544,770 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,846,610 | 524,593 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,458,848 | 191,308 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,973,315 | 140,750 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||